Skip to main content

Table 6 Estimated maternal and child health benefits of a 1-year inhaled oxytocin introduction program over a lifetime horizon with a 3% discount rate

From: Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings

  Bangladesh Ethiopia
Status quo Intervention Averted Status quo Intervention Averted
PPH cases, non-severe 291,978 278,813 13,165 297,868 295,672 2197
PPH cases, severe 150,947 145,467 5479 155,178 154,264 914
Maternal deaths 1806 1730 76 4418 4388 30
Maternal life years lost 46,429 44,475 1954 111,767 111,000 767
Child deaths 1135 1088 48 3394 3371 23
Child life years lost 33,480 32,071 1409 97,284 96,616 668
  1. PPH postpartum haemorrhage